These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31772387)

  • 1. Special issue: Nucleoside antibiotics, polyoxin and beyond.
    Osada H
    J Antibiot (Tokyo); 2019 Dec; 72(12):853-854. PubMed ID: 31772387
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery and applications of nucleoside antibiotics beyond polyoxin.
    Osada H
    J Antibiot (Tokyo); 2019 Dec; 72(12):855-864. PubMed ID: 31554959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular bases for the action and selectivity of nucleoside antibiotics.
    Carrasco L; Vázquez D
    Med Res Rev; 1984; 4(4):471-512. PubMed ID: 6208444
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics.
    Kimura KI
    J Antibiot (Tokyo); 2019 Dec; 72(12):877-889. PubMed ID: 31582803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A.
    Bu YY; Yamazaki H; Ukai K; Namikoshi M
    Mar Drugs; 2014 Dec; 12(12):6102-12. PubMed ID: 25522318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunicamycins, streptovirudins, and corynetoxins, a special subclass of nucleoside antibiotics.
    Eckardt K
    J Nat Prod; 1983; 46(4):544-50. PubMed ID: 6631437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the biosynthesis of nucleoside antibiotics.
    Shiraishi T; Kuzuyama T
    J Antibiot (Tokyo); 2019 Dec; 72(12):913-923. PubMed ID: 31554958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of nucleoside antibacterial natural product antibiotics.
    Bugg TDH; Kerr RV
    J Antibiot (Tokyo); 2019 Dec; 72(12):865-876. PubMed ID: 31471595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modular Approach to Phosphoglycosyltransferase Inhibitors Inspired by Nucleoside Antibiotics.
    Walvoort MT; Lukose V; Imperiali B
    Chemistry; 2016 Mar; 22(11):3856-64. PubMed ID: 26662170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of an industrial polyoxin producer for the targeted overproduction of designer nucleoside antibiotics.
    Qi J; Liu J; Wan D; Cai YS; Wang Y; Li S; Wu P; Feng X; Qiu G; Yang SP; Chen W; Deng Z
    Biotechnol Bioeng; 2015 Sep; 112(9):1865-71. PubMed ID: 25827606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, chemical reactivity, and chemotherapeutic activity of certain selenonucleosides and nucleosides related to the pyrrolo(2,3-d)pyrimidine nucleoside antibiotics.
    Townsend LB; Milne GH
    Ann N Y Acad Sci; 1975 Aug; 255():91-103. PubMed ID: 1059377
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
    Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
    Serpi M; Ferrari V; Pertusati F
    J Med Chem; 2016 Dec; 59(23):10343-10382. PubMed ID: 27607900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring nucleoside and nucleotide antibiotics.
    Suhadolnik RJ
    Prog Nucleic Acid Res Mol Biol; 1979; 22():193-291. PubMed ID: 230535
    [No Abstract]   [Full Text] [Related]  

  • 16. MraY-antibiotic complex reveals details of tunicamycin mode of action.
    Hakulinen JK; Hering J; Brändén G; Chen H; Snijder A; Ek M; Johansson P
    Nat Chem Biol; 2017 Mar; 13(3):265-267. PubMed ID: 28068312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside antibiotics: biosynthesis, regulation, and biotechnology.
    Niu G; Tan H
    Trends Microbiol; 2015 Feb; 23(2):110-9. PubMed ID: 25468791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi.
    Sobottka I; Bartscht K; Schäfer P; Weitzel T; Schottelius J; Kock N; Laufs R
    Parasitol Res; 2002 May; 88(5):451-3. PubMed ID: 12049463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.
    Kimura K; Bugg TD
    Nat Prod Rep; 2003 Apr; 20(2):252-73. PubMed ID: 12735700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical logic and enzymatic machinery for biological assembly of peptidyl nucleoside antibiotics.
    Walsh CT; Zhang W
    ACS Chem Biol; 2011 Oct; 6(10):1000-7. PubMed ID: 21851099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.